Description: Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.
Home Page: www.nanologica.com
Forskargatan 20G
Södertälje,
151 36
Sweden
Phone:
46 8 41 07 49 49
Officers
| Name | Title |
|---|---|
| Mr. Andreas Bhagwani | Chief Exec. Officer |
| Ms. Eva Osterman | Chief Financial Officer |
| Ms. Anna-Karin Renström | Chief Operating Officer |
| Mr. Gary Pitcairn | Chief Scientific Officer |
| Dr. P. K. Dutta | Sr. VP of Sales & Sr. Advisor of Chromatography |
| Ms. Katarina Alenas | Sr. VP of Chromatography |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 44.5028 |
| Price-to-Sales TTM: | 87.3953 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 20 |